448 related articles for article (PubMed ID: 17697780)
1. Follow-up care of patients with breast cancer.
Tolaney SM; Winer EP
Breast; 2007 Dec; 16 Suppl 2():S45-50. PubMed ID: 17697780
[TBL] [Abstract][Full Text] [Related]
2. Integrative tumor board: recurrent breast cancer or new primary? Naturopathic medicine.
Fulop JA
Integr Cancer Ther; 2003 Sep; 2(3):276-83. PubMed ID: 15035892
[No Abstract] [Full Text] [Related]
3. Integrative tumor board: recurrent breast cancer or new primary? Radiation oncology.
Hirsch A
Integr Cancer Ther; 2003 Sep; 2(3):272-6. PubMed ID: 15035891
[No Abstract] [Full Text] [Related]
4. Residual ductal carcinoma in situ in patients with complete eradication of invasive breast cancer after neoadjuvant chemotherapy does not adversely affect patient outcome.
Mazouni C; Peintinger F; Wan-Kau S; Andre F; Gonzalez-Angulo AM; Symmans WF; Meric-Bernstam F; Valero V; Hortobagyi GN; Pusztai L
J Clin Oncol; 2007 Jul; 25(19):2650-5. PubMed ID: 17602071
[TBL] [Abstract][Full Text] [Related]
5. Integrative tumor board: recurrent breast cancer or new primary? Medical oncology.
Boyd DB
Integr Cancer Ther; 2003 Sep; 2(3):270-2. PubMed ID: 15035890
[No Abstract] [Full Text] [Related]
6. Integrative tumor board: recurrent breast cancer or new primary? Case Presentation.
Schmaltz J
Integr Cancer Ther; 2003 Sep; 2(3):268-70. PubMed ID: 15035889
[No Abstract] [Full Text] [Related]
7. Development of new cancers in patients with DCIS: the M.D. Anderson experience.
Dawood S; Broglio K; Gonzalez-Angulo AM; Kau SW; Yang W; Albarracin C; Meric F; Hortobagyi G; Theriault R
Ann Surg Oncol; 2008 Jan; 15(1):244-9. PubMed ID: 18043978
[TBL] [Abstract][Full Text] [Related]
8. Ductal carcinoma in situ of the breast: our experience.
Ruggiero R; Procaccini E; Sanguinetti A; Cremone C; Gili S; Docimo G; Docimo L; Sparavigna L; Gubitosi A; Parmeggiani D; Avenia N
G Chir; 2009 Mar; 30(3):121-4. PubMed ID: 19351465
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer-specific mortality after invasive local recurrence in patients with ductal carcinoma-in-situ of the breast.
Lee LA; Silverstein MJ; Chung CT; Macdonald H; Sanghavi P; Epstein M; Holmes DR; Silberman H; Ye W; Lagios MD
Am J Surg; 2006 Oct; 192(4):416-9. PubMed ID: 16978940
[TBL] [Abstract][Full Text] [Related]
10. Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment with radiation for women with early-stage invasive breast carcinoma or ductal carcinoma in situ.
Solin LJ; Orel SG; Hwang WT; Harris EE; Schnall MD
J Clin Oncol; 2008 Jan; 26(3):386-91. PubMed ID: 18202414
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcome after selective treatment of patients diagnosed with ductal carcinoma in situ of the breast.
Meijnen P; Oldenburg HS; Peterse JL; Bartelink H; Rutgers EJ
Ann Surg Oncol; 2008 Jan; 15(1):235-43. PubMed ID: 17987342
[TBL] [Abstract][Full Text] [Related]
12. Integrative tumor board: recurrent breast cancer or new primary? Mind-body-spirit medicine.
Mehl-Madrona L
Integr Cancer Ther; 2003 Sep; 2(3):283-9. PubMed ID: 15035893
[No Abstract] [Full Text] [Related]
13. Ductal carcinoma in situ: through a glass, darkly.
Lagios MD; Silverstein MJ
Ann Surg Oncol; 2008 Jan; 15(1):16-7. PubMed ID: 18043977
[No Abstract] [Full Text] [Related]
14. Follow-up care in breast cancer.
Rutgers EJ
Expert Rev Anticancer Ther; 2004 Apr; 4(2):212-8. PubMed ID: 15056051
[TBL] [Abstract][Full Text] [Related]
15. [Ductal carcinoma in situ of the breast].
Procaccini E; Ruggiero R; Docimo G; Iovino F; Procaccini F; Gili S; Lo Schiavo F
G Chir; 2006; 27(1-2):40-4. PubMed ID: 16608632
[TBL] [Abstract][Full Text] [Related]
16. Bilateral breast MR imaging: is it superior to conventional methods for the detection of contralateral breast cancer?
Ozaki S; Tozaki M; Fukuma E; Kawano N; Suzuki T; Yamashiro N; Sakamoto M; Tsuruhara T; Sakamoto N; Higa K; Abe S; Ogawa T; Tsunoda Y; Nobuhito K
Breast Cancer; 2008; 15(2):169-74. PubMed ID: 18317885
[TBL] [Abstract][Full Text] [Related]
17. Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: a meta-analysis.
Lu WL; Jansen L; Post WJ; Bonnema J; Van de Velde JC; De Bock GH
Breast Cancer Res Treat; 2009 Apr; 114(3):403-12. PubMed ID: 18421576
[TBL] [Abstract][Full Text] [Related]
18. [Follow-up of breast cancer: review of 750 cases after 5 years].
Martínez-Regueira F; Díez-Caballero A; Sierra A; Espí A; Baixauli J; Zornoza A
Rev Med Univ Navarra; 1998; 42(1):7-13. PubMed ID: 10420951
[TBL] [Abstract][Full Text] [Related]
19. Long-term cosmesis after lumpectomy and brachytherapy in the management of carcinoma of the previously irradiated breast.
Trombetta M; Julian TB; Werts DE; McWilliams W; Kim Y; Miften M; Parda D
Am J Clin Oncol; 2009 Jun; 32(3):314-8. PubMed ID: 19451803
[TBL] [Abstract][Full Text] [Related]
20. [Initial experiences with CA-15-3 determination in the serum of patients with breast cancer].
Bartel U; Johannsen B; Reiss H; Elling D
Zentralbl Gynakol; 1989; 111(21):1417-24. PubMed ID: 2557715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
